Skip to content

SCREENER CHART SD50 CALENDAR NEWS

...

Adaptimmune Therapeutics plc (ADAP) Stock · SELL · CRISIS | LOPJLB

Adaptimmune Therapeutics plc (ADAP)

Healthcare

$0.05+0.00%Close

SELLCRISIS · day 7

ADAP▼ SELL

$0.05+0.00%

Overview FinancialsFin EarningsEarn Analyst & RatingsAnalyst News Holders & ETFsHold Options

Key stats

Market cap: $75M

Prediction markets

Kalshi · Polymarket · … linked

Full prediction markets →

Loading markets…

Company

Sector: Healthcare

FUNDAMENTALS

NO COVERAGE

Company news

Loading headlines…

Market news & ticker search · RSS for ADAP

FAQ

What is LOPJLB’s current signal on ADAP?: LOPJLB’s latest quantitative signal on Adaptimmune Therapeutics plc (ADAP) is SELL in a CRISIS regime. Signals are updated daily.
What market regime is ADAP in?: Adaptimmune Therapeutics plc (ADAP) is currently classified in the CRISIS HMM market regime on LOPJLB.

LOPJLB

Independent quant research on U.S. equities & ETFs. Not personalized advice.

Product

Screener Chart Compare SD50 Thesis News Calendar

Desk

Market Heatmap Market Hours FOMC Desk Treasury Rates Congress Trades Prediction Markets

Research

How It Works Methodology Track Record Docs Editorial Blog Changelog

Ledgers

Bull Spreads Cash-Secured Puts Covered Calls Long Puts Long Calls

Screeners

CEF Screener REIT Screener BDC Screener Preferred Screener Dividend Screener ETF Screener Crypto Screener S&P 500 Screener Best dividend stocks Undervalued stocks Best S&P 500 stocks

Company

Pricing About Contact

Agents

GitHub·Research Chat·MCPENT·Developers

© 2026 LOPJLB Research. All rights reserved.

@lopjlb contact@lopjlb.com